| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
FiWare is a Norcross, GA-based company in the Software and Internet sector.
Onfido is the new identity standard for the internet. Our AI-based technology assesses whether a user`s government-issued ID is genuine or fraudulent, and then compares it against their facial biometrics. That`s how we give companies like Revolut, Zipcar and Bitstamp the assurance they need to onboard customers remotely and securely. Our mission is to create a more open world, where identity is the key to access.
Smarsh is a multinational "software as a service" company headquartered in Portland, Oregon, with nine offices worldwide including locations in, New York, Redwood City, California, Boston, Raleigh, North Carolina, London and Bangalore, India.